Results 31 to 40 of about 1,299 (139)

Medicinal and Crop Protection Chemistry: Breaking Barriers, Building Synergies

ChemMedChem, Volume 21, Issue 16, 27 August 2026.
A unified view of medicinal and crop protection chemistry reveals shared scientific progress, common challenges, and new opportunities for cross‐disciplinary collaboration. Bridging expertise across both fields could accelerate innovation and actively encourage more sustainable solutions.
Giulia Cazzaniga, Giusy L. Fratello, Alexander T. Apostle, Roberto Orru, David M. Barber, Silvia Gazzola   +5 more
wiley   +1 more source

Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin

BMC Infectious Diseases, 2019
Background Solithromycin, the fourth generation of ketolides, has been demonstrated potent antibacterial effect against commonly-isolated gram-positive strains. However, Staphylococcus aureus (S.
Weiming Yao, Guangjian Xu, Duoyun Li, Bing Bai, Hongyan Wang, Hang Cheng, Jinxin Zheng, Xiang Sun, Zhiwei Lin, Qiwen Deng, Zhijian Yu   +10 more
doaj   +1 more source

Analysis of Virulence Genes and Antibiotic‐Resistant Profiles of Campylobacter in Huzhou, China

Canadian Journal of Infectious Diseases and Medical Microbiology, Volume 2026, Issue 1, 2026.
Background Campylobacter is the leading bacterial cause of diarrheal illnesses worldwide. Campylobacter jejuni and Campylobacter coli are the main pathogens of Campylobacter infections. Drug‐resistant Campylobacter has been classified as a serious antibiotic resistance threat. Methods From 2021 to 2022, 68 Campylobacter were isolated from fecal samples
Xiaofang Wu, Fenfen Dong, Zhonghao Lu, Lei Ji, Liping Chen, Satabdi Datta Choudhury   +5 more
wiley   +1 more source

Leclercia adecarboxylata Cholecystitis with Septic Shock in Immunocompetent Patient

Case Reports in Critical Care, Volume 2019, Issue 1, 2019., 2019
L. adecarboxylata is a Gram‐negative rod previously named Escherichia adecarboxylata, isolated as normal flora in the gut of animals including human stool. Most reported cases refer to immunocompromised patients with polymicrobial infections and water environments.
Nooraldin Merza, John Lung, Ahmed Taha, Ahmed Qasim, Jill Frost, Tarek Naguib, Mehmet Doganay   +6 more
wiley   +1 more source

Increased susceptibility to azithromycin of Pseudomonas aeruginosa biofilms using RPMI 1640 testing media

APMIS, Volume 132, Issue 12, Page 1086-1095, December 2024.
Azithromycin (AZM) is efficient for treatment of chronic Pseudomonas aeruginosa biofilm lung infections, despite of resistance in conventional susceptibility testing. It has been shown that planktonic P. aeruginosa are more susceptible to AZM when tested in RPMI 1640 medium. The aim of the study was to test the susceptibility to AZM of P.
Adrian Jimenez San San Mauro, Niels Høiby, Oana Ciofu   +2 more
wiley   +1 more source

Current Perspectives on Treatment of Gram‐Positive Infections in India: What Is the Way Forward?

Interdisciplinary Perspectives on Infectious Diseases, Volume 2019, Issue 1, 2019., 2019
The emerging antimicrobial resistance leading to gram‐positive infections (GPIs) is one of the major public health threats worldwide. GPIs caused by multidrug resistant bacteria can result in increased morbidity and mortality rates along with escalated treatment cost and hospitalisation stay.
Atul P. Kulkarni, Vasant C. Nagvekar, Balaji Veeraraghavan, Anup R. Warrier, Deepak TS, Jaishid Ahdal, Rishi Jain, Adalberto R. Santos   +7 more
wiley   +1 more source

Ketolides : pharmacological profile and rational positioning in the treatment of respiratory tract infections

, 2008
Ketolides differ from macrolides by removal of the 3-O-cladinose (replaced by a keto group), a 11,12- or 6,11-cyclic moiety and a heteroaryl-alkyl side chain attached to the macrocyclic ring through a suitable linker.
Joerg M Harms, Van Bambeke, Françoise, Van Laethem, Yves, Harms, Joerg J.M., Harms, Joerg M, Françoise Van Bambeke, Tulkens, Paul M., Vanlaethem, Yves, Yves Van Laethem, Paul M Tulkens   +9 more
core   +1 more source

Telitromicine. A new therapeutic option from macrolides to ketolides.

Medisur, 2004
-
Pedro Miguel Milián Vázquez., Maira Quirós Enríquez., Arlette Linares Borges.   +2 more
doaj   +2 more sources

Cross‐reactivity among and between macrolides, lincosamides, and streptogramins: Study on the French pharmacovigilance database

Fundamental &Clinical Pharmacology, Volume 38, Issue 5, Page 988-997, October 2024.
Abstract Background Hypersensitivity reactions (HSR) are reported for the macrolides, lincosamides, and streptogramins (MLS) antibiotic family. Data about cross‐reactivity among and between MLS remain scarce or controversial. Objectives The aim of this study was to provide an overview of hypersensitivity cross‐reactions among MLSs based on data ...
Quentin Le Baron, Delphine Bourneau‐Martin, Marina Babin, Aurore Gouraud, Marie Tauber, Audrey Fresse, Bénédicte Lebrun‐Vignes, Juliette Delaunay, Martine Morisset, Marie Briet   +9 more
wiley   +1 more source

ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food‐producing animals

EFSA Journal, Volume 15, Issue 10, October 2017., 2017
Abstract ECDC, EFSA and EMA have jointly established a list of harmonised outcome indicators to assist EU Member States in assessing their progress in reducing the use of antimicrobials and antimicrobial resistance (AMR) in both humans and food‐producing animals. The proposed indicators have been selected on the basis of data collected by Member States
ECDC, EFSA Panel on Biological Hazards (BIOHAZ), EMA Committee for Medicinal Products for Veterinary Use (CVMP)   +2 more
wiley   +1 more source